Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 426 to 450 of 1160 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
735 decreased cholesterol transport (GO:0030301) cholesteryl ester (CHEBI:17002) 807: Decreased, cholesterol
734 decreased cholesterol transport (GO:0030301) cholesterol (CHEBI:16113) 807: Decreased, cholesterol
733 abnormal Abnormal spermatogenesis (HP:0008669) Mature sperm cell (FMA:67338) 1758: Impaired, Spermatogenesis
732 disrupted androgen receptor signaling pathway (GO:0030521) Musculature of male perineum (FMA:264621) 1688: anogenital distance (AGD), decreased
731 decreased fin regeneration (GO:0031101) blastemal cell (CL:0000354) 1761: Inhibition, Fin regeneration
730 decreased activin receptor signaling pathway (GO:0032924) activin receptor complex (GO:0048179) None
729 decreased activin receptor signaling pathway (GO:0032924) activin complex (GO:0048180) None
728 increased gene expression (GO:0010467) teratocarcinoma-derived growth factor 1 (PR:000030513) None
727 decreased androgen biosynthetic process (GO:0006702) 11-Keto-testosterone (CHEBI:34133) 1756: Decreased, plasma 11-ketotestosterone level
726 decreased androgen biosynthetic process (GO:0006702) None
725 increased Wnt protein secretion (GO:0061355) protein-serine O-palmitoleoyltransferase porcupine (PR:000030936) 1754: Increase, porcupine-induced Wnt secretion and Wnt signaling activation
724 increased G-protein coupled acetylcholine receptor binding (GO:0031789) muscarinic acetylcholine receptor (PR:000001488) 1602: Increased Muscarinic Acetylcholine Receptors
723 increased Testicular atrophy (HP:0000029) Testis (FMA:7210) 1506: Testicular atrophy
722 disrupted tubulin complex (GO:0045298) 718: Binding, Tubulin
721 increased DNA molecule region (FMA:84119) None
720 decreased phagocytosis (GO:0006909) macrophage (CL:0000235) 1668: Frustrated phagocytosis
719 increased hypoxia-inducible factor-1alpha signaling pathway (GO:0097411) None
718 decreased hypoxia-inducible factor-1alpha signaling pathway (GO:0097411) von Hippel-Lindau disease tumor suppressor (PR:000017294) None
717 decreased hypoxia (MP:0005039) von Hippel-Lindau disease tumor suppressor (PR:000017294) 1394: Induction, persistent proliferation/sustained proliferation
716 decreased hypoxia (MP:0005039) hypoxia-inducible factor 1-alpha (PR:000008555) 1394: Induction, persistent proliferation/sustained proliferation
715 increased macrophage activation involved in immune response (GO:0002281) macrophage (CL:0000235) 1394: Induction, persistent proliferation/sustained proliferation
714 increased cellular response to oxidative stress (GO:0034599) 1394: Induction, persistent proliferation/sustained proliferation
713 decreased abnormal circulating hormone level (MP:0005418) None
712 decreased abnormal circulating hormone level (MP:0005418) 3,3',5-triiodo-L-thyronine (CHEBI:18258) None
711 decreased abnormal circulating hormone level (MP:0005418) 3,3',5'-triiodothyronine (CHEBI:28774) None